Toggle navigation
About Us
Science & Innovation
Products and Resources
Our Responsibility
Careers
Investors
Media
Toggle navigation
Press Releases
Featured News
Press Statements
Subscribe
Media Contacts
Social Media
Press Releases
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Jun 2, 2005
Landmark Taxotere® Study in Early Stage Breast Cancer Published in the New England Journal of Medicine
May 31, 2005
Sanofi-aventis Annual General Meeting
May 25, 2005
UROXATRAL® (alfuzosin HCl) STUDY SHOWS IMPROVEMENT UP TO TWO YEARS IN LOWER URINARY TRACT SYMPTOMS AND SEXUAL FUNCTION IN MEN WITH ENLARGED PROSTATES
May 24, 2005
New Study Demonstrates Clinical Efficacy of Telithromycin Superior to Standard First-Line Antibiotic Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia (CAP)
May 23, 2005
New Data Demonstrate Alvesco® (ciclesonide) Significantly Reduces Oral Corticosteroid Use in Patients with Severe, Persistent Asthma
May 15, 2005
Taxotere® Regimen Demonstrates Significant Survival Benefit In The Treatment Of Advanced Gastric Cancer
May 13, 2005
Sanofi-aventis 2005 first-quarter net sales
May 10, 2005
Rescheduling of the pre-trial order date in the United States Plavix® litigation
May 10, 2005
New Eloxatin® and Taxotere® research to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO)
Apr 15, 2005
Sanofi-aventis affirms its commitment to Access to Medicines in the "Southern countries", with a policy of tiered drug prices geared to populations incomes
Apr 11, 2005
FDA issues approvable letter for AMBIEN CR™ (zolpidem tartrate extended release) C IV for the treatment of Insomnia
Apr 7, 2005
Sanofi-aventis Statement
Apr 1, 2005
Sanofi-aventis concludes €10 billion in medium-term credit agreements with its banks to refinance the Aventis acquisition financing entered into in April 2004
Mar 30, 2005
Rescheduling of the pre-trial order date in the United States Plavix® litigation
Mar 24, 2005
Sanofi-aventis joins the fight against tuberculosis in South Africa
Mar 22, 2005
New Data Demonstrate Alvesco® (ciclesonide) Has a Low Incidence of Mouth- and Throat- Related Side Effects in Pediatric Asthma Patients
Mar 22, 2005
New Data Demonstrate Alvesco® (ciclesonide) Significantly Improves Quality-of-Life for Patients with Mild-to-Moderate Asthma
Mar 22, 2005
Court grants Sanofi-aventis's request for Order of Prohibition in the Canadian Plavix® litigation
Mar 11, 2005
SANOFI-AVENTIS SUES NOVOPHARM FOR PATENT INFRINGEMENT IN CANADA
Mar 9, 2005
CLOPIDOGREL IMPROVED CORONARY PERFUSION AND REDUCED MORTALITY IN ACUTE HEART ATTACK
Mar 2, 2005
PFIZER AND THE SANOFI-AVENTIS GROUP SEEK APPROVAL TO MARKET EXUBERA® IN THE UNITED STATES
Mar 1, 2005
Sanofi-aventis 2004 Results
Feb 24, 2005
Creation of the sanofi-aventis European Works Council
Feb 24, 2005
First Pilot Study to Show Benefit Using Hyalgan® (sodium hyaluronate) in the Treatment of Osteoarthritis of the Ankle
Feb 23, 2005
Update of the Patent Litigation Schedule in the United States for Plavix®
Feb 18, 2005
Sanofi-aventis world solidarity day on behalf of South East Asia - January 25, 2005: "Sharing in solidarity"
Feb 17, 2005
Sanofi-aventis announces commercial availability of twice-yearly Eligard®
Feb 2, 2005
Sanofi-aventis receives FDA approval for new Eloxatin™ formulation
Jan 26, 2005
2004 pro forma combined net sales: up 10.0% on a comparable basis
Jan 25, 2005
Plavix® patent
Jan 25, 2005
Sanofi-aventis “Solidarity Day” offers additional aid, assistance to Southeast Asia “Sharing in solidarity”
Jan 19, 2005
The European Commission imposes a fine on certain MCAA producers
Jan 11, 2005
Taxotere® (docetaxel) receives 2 new European approvals for treatment of breast cancer
Jan 11, 2005
New Together Rx Access™ Card offers Americans with no prescription drug coverage savings at the pharmacy counter
Jan 10, 2005
Sanofi-aventis and Regeneron Pharmaceuticals reaffirm development commitment
Jan 10, 2005
Aventis Pasteur, the vaccine division of the sanofi-aventis Group, changes its name to sanofi Pasteur
Jan 6, 2005
Update of the patent litigation schedule in the United States for Plavix®
Jan 3, 2005
Sanofi-aventis provides Humanitarian Aid for South-East Asia
Show
5
10
25
50
100
per page
«
1
…
9
10
11
12
13
14
15
16
17
»
Print
Email page
RSS